查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1507233

癌症疼痛管理市場、佔有率、規模、趨勢、行業分析報告：依疼痛類型、依藥物類型、依癌症類型、依應用、依最終用途、依地區、依細分市場、預測，2024-2032年

Cancer Pain Management Market Share, Size, Trends, Industry Analysis Report, By Pain Type (Acute Pain, Chronic Pain); By Drug Type; By Cancer Type; By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，到2032年，全球癌症疼痛治療市場規模預計將達到 83.9 億美元。本研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

癌症疼痛管理市場快速成長。癌症疼痛的範圍可以從輕微到嚴重，並且以多種方式表現，包括尖銳的刺痛、疼痛、灼熱感和持續性疼痛。癌症疼痛對生活品質有重大影響，並使癌症症狀和治療副作用惡化。此外，更有可能患上憂鬱和焦慮。因此，適當的疼痛管理在癌症治療中極為重要。

此外，癌症護理管理服務致力於在患者的整個癌症治療過程中優化症狀管理，包括疼痛管理。根據每位患者的獨特需求和偏好提供全面、富有同情心的照護。有效的癌症疼痛管理需要腫瘤學家、疼痛專家、癌症護理團隊、護士、社會工作者和其他醫療保健專業人員共同努力，以滿足癌症患者複雜和個性化的需求。

近年來，針灸已成為緩解慢性疼痛的有效方法。這種傳統中醫治療方法是將細針插入皮膚的特定區域並進行操作。儘管科學研究已經證明針灸對某些類型的疼痛有效，但其在治療癌症相關疼痛方面的有效性證據有限。經皮神經電刺激（TENS）療法使用透過放置在皮膚上的電極的低水平電流來引起身體反應並緩解疼痛。

癌症疼痛管理市場報告重點

具有緩解中度至重度疼痛特性的鴉片類藥物在市場上佔據主導地位。

非鴉片類藥物領域預計在預測期內將以年複合成長率成長，因為它主要有效治療輕度至中度疼痛。

由於肺癌盛行率不斷上升以及與肺癌相關的疼痛頻率較高，肺癌細分市場佔據了最大的市場佔有率。

由於病患對醫院環境的偏好和信任不斷提高，醫院領域顯著加速了市場的發展。

由於癌症盛行率上升和醫療服務需求不斷成長，北美地區主導了市場。

目錄

第1章 簡介

第2章 執行摘要

第3章 研究方法

第4章 全球癌症疼痛管理市場洞察

  • 癌症疼痛管理 - 產業概況
  • 癌症疼痛管理市場動態
    • 推動因素和機會
      • 人口老化加劇
      • 癌症疼痛管理技術的進步
    • 抑制因素和挑戰
      • 治療費用高
  • PESTLE分析
  • 癌痛治療產業的趨勢
  • 新冠肺炎（COVID-19）影響分析

第5章 全球癌痛治療市場：依疼痛類型

  • 主要發現
  • 簡介
  • 劇烈疼痛
  • 慢性疼痛

第6章 全球癌痛治療市場：依藥物類型

  • 主要發現
  • 簡介
  • 鴉片類藥物
  • 非鴉片類藥物
  • 皮質類固醇
  • 抗憂鬱藥
  • 抗焦慮藥
  • 抗驚厥藥
  • 抗精神病藥物

第7章 全球癌症疼痛治療市場：依癌症類型

  • 主要發現
  • 簡介
  • 肺癌
  • 大腸癌
  • 乳癌
  • 攝護腺癌
  • 血癌
  • 其他

第8章 全球癌痛治療市場：依應用分類

  • 主要發現
  • 簡介
  • 免疫治療
  • 化療
  • 放射治療
  • 家庭治療
  • 其他

第9章 全球癌痛治療市場：依最終用途分類

  • 主要發現
  • 簡介
  • 醫院
  • 癌症治療診所
  • 其他

第10章 全球癌痛治療市場：依地區

  • 主要發現
  • 簡介
    • 癌症疼痛管理市場評估：依地區，2019-2032年
  • 北美
    • 北美：依疼痛類型，2019-2032年
    • 北美：依應用，2019-2032年
    • 北美：依藥物類型，2019-2032年
    • 北美：依癌症類型，2019-2032年
    • 北美：依最終用途，2019-2032年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲：依疼痛類型，2019-2032年
    • 歐洲：依應用，2019-2032年
    • 歐洲：依藥物類型，2019-2032年
    • 歐洲：依癌症類型，2019-2032年
    • 歐洲：依最終用途，2019-2032年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
  • 亞太地區
    • 亞太地區：依疼痛類型，2019-2032年
    • 亞太地區：依應用，2019-2032年
    • 亞太地區：依藥物類型，2019-2032年
    • 亞太地區：依癌症類型，2019-2032年
    • 亞太地區：依最終用途，2019-2032年
    • 中國
    • 印度
    • 日本
    • 馬來西亞
    • 印尼
    • 韓國
  • 中東、非洲
    • 中東和非洲：依疼痛類型，2019-2032年
    • 中東與非洲：依應用，2019-2032年
    • 中東和非洲：依藥物類型，2019-2032年
    • 中東和非洲：依癌症類型，2019-2032年
    • 中東和非洲：依最終用途，2019-2032年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
  • 拉丁美洲
    • 拉丁美洲：依疼痛類型，2019-2032年
    • 拉丁美洲：依應用，2019-2032年
    • 拉丁美洲：依藥物類型，2019-2032年
    • 拉丁美洲：依癌症類型，2019-2032年
    • 拉丁美洲：依最終用途，2019-2032年
    • 墨西哥
    • 巴西
    • 阿根廷

第11章 競爭態勢

  • 擴張與收購分析
    • 擴張
    • 收購
  • 夥伴關係/協作/協議/揭露

第12章 公司簡介

  • BioDelivery Sciences
  • Daiichi Sankyo
  • Eli Lilly & Company
  • Endo Pharmaceuticals
  • Johnson & Johnson Inc
  • Mallinckrodt Pharmaceuticals
  • Pfizer Inc
  • Prostrakan Group
  • Sanofi S.A.
  • Teva Pharmaceuticals
Product Code: PM1320

The global cancer pain management market size is expected to reach USD 8.39 billion by 2032, according to a new study by Polaris Market Research. The report "Cancer Pain Management Market Share, Size, Trends, Industry Analysis Report, By Pain Type (Acute Pain, Chronic Pain); By Drug Type; By Cancer Type; By Application; By End-Use; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The cancer pain management market is witnessing rapid growth. Cancer pain can range from mild to severe and present in various forms, such as sharp stabbing pain, tingling, burning sensation, or a persistent ache. The impact of cancer pain on your quality of life is significant, worsening cancer symptoms and treatment side effects. Additionally, it can heighten the likelihood of developing depression and anxiety. Therefore, proper pain management is crucial in cancer treatment.

Additionally, cancer care management services focus on optimizing symptom management, including pain control, throughout the cancer journey of the patient. They provide holistic and compassionate care tailored to each patient's unique needs and preferences. Effective cancer pain management requires a collaborative effort from oncologists, pain specialists, cancer care teams, nurses, social workers, and other healthcare professionals to address the complex and individualized needs of cancer patients.

In recent years, additional methods that could be beneficial in alleviating chronic pain include acupuncture. This traditional Chinese medicine practice entails the insertion and manipulation of thin needles into specific areas of the skin. While scientific research has demonstrated the effectiveness of acupuncture in treating certain types of pain, there is limited evidence regarding its efficacy in managing cancer-related pain. Transcutaneous electrical nerve stimulation (TENS) therapy involves the application of a low-level electrical current through electrodes placed on the skin, eliciting a response from the body that helps alleviate pain.

Cancer Pain Management Market Report Highlights

The opioids segment dominated the market, largely attributable to their property to alleviate moderate to severe pain.

The non-opioids drug segment is projected to grow at a CAGR during the projected period, mainly driven by its effectiveness in managing mild to moderate pain.

The lung cancer segment accounted for the largest market share, attributed to the rising prevalence of lung cancer, a higher frequency of pain related to lung cancer.

The hospitals segment dominated the market highly accelerated due to the increasing preference and trust of patients towards hospital settings.

The North America region dominated the market attributed to the increasing prevalence of cancer has created a greater demand for healthcare services.

The global key market players include BioDelivery Sciences, Daiichi Sankyo, Eli Lilly & Company, Endo Pharmaceuticals, Johnson & Johnson Inc., etc.

Polaris Market Research has segmented the cancer pain management market report based on pain type, drug type, cancer type, application, end-use, and region:

Cancer Pain Management, Pain Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Acute Pain
  • Chronic Pain

Cancer Pain Management, Drug Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Opioid
  • Morphine
  • Fentanyl
  • Others
  • Non-opioids
  • Non-steroidal anti-inflammatory drug
  • Acetaminophen
  • Corticosteroids
  • Anti-depressants
  • Anti-anxiety drugs
  • Anti-convulsant drugs
  • Nerve Blockers

Cancer Pain Management, Cancer Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Lung Cancer
  • Colorectal cancer
  • Breast cancer
  • Prostate cancer
  • Blood cancer
  • Others

Cancer Pain Management, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Immunotherapy
  • Chemotherapy
  • Radiotherapy
  • Home Therapy
  • Others

Cancer Pain Management, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals
  • Cancer Care Clinics
  • Others

Cancer Pain Management, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Australia
  • Malaysia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cancer Pain Management Market Insights

  • 4.1. Cancer Pain Management - Industry Snapshot
  • 4.2. Cancer Pain Management Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Geriatric Population
      • 4.2.1.2. Rising Technology in Cancer Pain Management
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Treatment Costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Cancer Pain Management Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global Cancer Pain Management Market, by Pain Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • 5.3. Acute Pain
    • 5.3.1. Global Cancer Pain Management Market, by Acute Pain, by Region, 2019-2032 (USD Billion)
  • 5.4. Chronic Pain
    • 5.4.1. Global Cancer Pain Management Market, by Chronic Pain, by Region, 2019-2032 (USD Billion)

6. Global Cancer Pain Management Market, by Drug Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • 6.3. Opioid
    • 6.3.1. Global Cancer Pain Management Market, by Opioid, by Region, 2019-2032 (USD Billion)
    • 6.3.2. Morphine
      • 6.3.2.1. Global Cancer Pain Management Market, by Morphine, by Region, 2019-2032 (USD Billion)
    • 6.3.3. Fentanyl
      • 6.3.3.1. Global Cancer Pain Management Market, by Fentanyl, by Region, 2019-2032 (USD Billion)
    • 6.3.4. Others
      • 6.3.4.1. Global Cancer Pain Management Market, by Others, by Region, 2019-2032 (USD Billion)
  • 6.4. Non-opioids
    • 6.4.1. Global Cancer Pain Management Market, by Non-opioids, by Region, 2019-2032 (USD Billion)
    • 6.4.2. Non-steroidal anti-inflammatory drug
      • 6.4.2.1. Global Cancer Pain Management Market, by Non-steroidal anti-inflammatory drug, by Region, 2019-2032 (USD Billion)
    • 6.4.3. Acetaminophen
      • 6.4.3.1. Global Cancer Pain Management Market, by Acetaminophen, by Region, 2019-2032 (USD Billion)
  • 6.5. Corticosteroids
    • 6.5.1. Global Cancer Pain Management Market, by Corticosteroids, by Region, 2019-2032 (USD Billion)
  • 6.6. Anti-depressants
    • 6.6.1. Global Cancer Pain Management Market, by Anti-depressants, by Region, 2019-2032 (USD Billion)
  • 6.7. Anti-anxiety drugs
    • 6.7.1. Global Cancer Pain Management Market, by Anti-anxiety drugs, by Region, 2019-2032 (USD Billion)
  • 6.8. Anti-convulsant drugs
    • 6.8.1. Global Cancer Pain Management Market, by Anti-convulsant drugs, by Region, 2019-2032 (USD Billion)
  • 6.9. Nerve Blockers
    • 6.9.1. Global Cancer Pain Management Market, by Nerve Blockers, by Region, 2019-2032 (USD Billion)

7. Global Cancer Pain Management Market, by Cancer Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • 7.3. Lung Cancer
    • 7.3.1. Global Cancer Pain Management Market, by Lung Cancer, by Region, 2019-2032 (USD Billion)
  • 7.4. Colorectal cancer
    • 7.4.1. Global Cancer Pain Management Market, by Colorectal cancer, by Region, 2019-2032 (USD Billion)
  • 7.5. Breast cancer
    • 7.5.1. Global Cancer Pain Management Market, by Breast cancer, by Region, 2019-2032 (USD Billion)
  • 7.6. Prostate cancer
    • 7.6.1. Global Cancer Pain Management Market, by Prostate cancer, by Region, 2019-2032 (USD Billion)
  • 7.7. Blood cancer
    • 7.7.1. Global Cancer Pain Management Market, by Blood cancer, by Region, 2019-2032 (USD Billion)
  • 7.8. Others
    • 7.8.1. Global Cancer Pain Management Market, by Others, by Region, 2019-2032 (USD Billion)

8. Global Cancer Pain Management Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • 8.3. Immunotherapy
    • 8.3.1. Global Cancer Pain Management Market, by Immunotherapy, by Region, 2019-2032 (USD Billion)
  • 8.4. Chemotherapy
    • 8.4.1. Global Cancer Pain Management Market, by Chemotherapy, by Region, 2019-2032 (USD Billion)
  • 8.5. Radiotherapy
    • 8.5.1. Global Cancer Pain Management Market, by Radiotherapy, by Region, 2019-2032 (USD Billion)
  • 8.6. Home Therapy
    • 8.6.1. Global Cancer Pain Management Market, by Home Therapy, by Region, 2019-2032 (USD Billion)
  • 8.7. Others
    • 8.7.1. Global Cancer Pain Management Market, by Others, by Region, 2019-2032 (USD Billion)

9. Global Cancer Pain Management Market, by End-Use

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • 9.3. Hospitals
    • 9.3.1. Global Cancer Pain Management Market, by Hospitals, by Region, 2019-2032 (USD Billion)
  • 9.4. Cancer Care Clinics
    • 9.4.1. Global Cancer Pain Management Market, by Cancer Care Clinics, by Region, 2019-2032 (USD Billion)
  • 9.5. Others
    • 9.5.1. Global Cancer Pain Management Market, by Others, by Region, 2019-2032 (USD Billion)

10. Global Cancer Pain Management Market, by Geography

  • 10.1. Key findings
  • 10.2. Introduction
    • 10.2.1. Cancer Pain Management Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 10.3. Cancer Pain Management Market - North America
    • 10.3.1. North America: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
    • 10.3.2. North America: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
    • 10.3.3. North America: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
    • 10.3.4. North America: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
    • 10.3.5. North America: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.3.6. Cancer Pain Management Market - U.S.
      • 10.3.6.1. U.S.: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.3.6.2. U.S.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.3.6.3. U.S.: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.3.6.4. U.S.: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.3.6.5. U.S.: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.3.7. Cancer Pain Management Market - Canada
      • 10.3.7.1. Canada: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.3.7.2. Canada.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.3.7.3. Canada: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.3.7.4. Canada: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.3.7.5. Canada: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • 10.4. Cancer Pain Management Market - Europe
    • 10.4.1. Europe: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
    • 10.4.2. Europe.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
    • 10.4.3. Europe: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
    • 10.4.4. Europe: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
    • 10.4.5. Europe: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.6. Cancer Pain Management Market - UK
      • 10.4.6.1. UK: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.6.2. UK.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.6.3. UK: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.6.4. UK: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.6.5. UK: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.7. Cancer Pain Management Market - France
      • 10.4.7.1. France: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.7.2. France.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.7.3. France: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.7.4. France: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.7.5. France: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.8. Cancer Pain Management Market - Germany
      • 10.4.8.1. Germany: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.8.2. Germany.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.8.3. Germany: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.8.4. Germany: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.8.5. Germany: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.9. Cancer Pain Management Market - Italy
      • 10.4.9.1. Italy: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.9.2. Italy.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.9.3. Italy: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.9.4. Italy: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.9.5. Italy: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.10. Cancer Pain Management Market - Spain
      • 10.4.10.1. Spain: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.10.2. Spain.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.10.3. Spain: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.10.4. Spain: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.10.5. Spain: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.11. Cancer Pain Management Market - Netherlands
      • 10.4.11.1. Netherlands: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.11.2. Netherlands.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.11.3. Netherlands: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.11.4. Netherlands: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.11.5. Netherlands: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.4.12. Cancer Pain Management Market - Russia
      • 10.4.12.1. Russia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.4.12.2. Russia.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.4.12.3. Russia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.4.12.4. Russia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.4.12.5. Russia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • 10.5. Cancer Pain Management Market - Asia Pacific
    • 10.5.1. Asia Pacific: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
    • 10.5.2. Asia Pacific.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
    • 10.5.3. Asia Pacific: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
    • 10.5.4. Asia Pacific: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
    • 10.5.5. Asia Pacific: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.5.6. Cancer Pain Management Market - China
      • 10.5.6.1. China: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.5.6.2. China.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.5.6.3. China: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.6.4. China: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.5.6.5. China: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.5.7. Cancer Pain Management Market - India
      • 10.5.7.1. India: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.5.7.2. India.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.5.7.3. India: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.7.4. India: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.5.7.5. India: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.5.8. Cancer Pain Management Market - Japan
      • 10.5.8.1. Japan: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.5.8.2. Japan.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.5.8.3. Japan: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.8.4. Japan: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.5.8.5. Japan: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.5.9. Cancer Pain Management Market - Malaysia
      • 10.5.9.1. Malaysia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.5.9.2. Malaysia.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.5.9.3. Malaysia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.9.4. Malaysia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.5.9.5. Malaysia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.5.10. Cancer Pain Management Market - Indonesia
      • 10.5.10.1. Indonesia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.5.10.2. Indonesia.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.5.10.3. Indonesia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.10.4. Indonesia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.5.10.5. Indonesia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.5.11. Cancer Pain Management Market - South Korea
      • 10.5.11.1. South Korea: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.5.11.2. South Korea.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.5.11.3. South Korea: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.5.11.4. South Korea: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.5.11.5. South Korea: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • 10.6. Cancer Pain Management Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
    • 10.6.2. Middle East & Africa: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
    • 10.6.3. Middle East & Africa: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
    • 10.6.4. Middle East & Africa: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
    • 10.6.5. Middle East & Africa: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.6.6. Cancer Pain Management Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.6.6.2. Saudi Arabia.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.6.7. Cancer Pain Management Market - UAE
      • 10.6.7.1. UAE: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.6.7.2. UAE.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.6.7.3. UAE: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.6.7.4. UAE: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.6.7.5. UAE: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.6.8. Cancer Pain Management Market - Israel
      • 10.6.8.1. Israel: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.6.8.2. Israel.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.6.8.3. Israel: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.6.8.4. Israel: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.6.8.5. Israel: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.6.9. Cancer Pain Management Market - South Africa
      • 10.6.9.1. South Africa: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.6.9.2. South Africa.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.6.9.3. South Africa: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.6.9.4. South Africa: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.6.9.5. South Africa: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • 10.7. Cancer Pain Management Market - Latin America
    • 10.7.1. Latin America: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
    • 10.7.2. Latin America.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
    • 10.7.3. Latin America: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
    • 10.7.4. Latin America: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
    • 10.7.5. Latin America: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.7.6. Cancer Pain Management Market - Mexico
      • 10.7.6.1. Mexico: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.7.6.2. Mexico.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.7.6.3. Mexico: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.7.6.4. Mexico: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.7.6.5. Mexico: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.7.7. Cancer Pain Management Market - Brazil
      • 10.7.7.1. Brazil: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.7.7.2. Brazil.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.7.7.3. Brazil: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.7.7.4. Brazil: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.7.7.5. Brazil: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
    • 10.7.8. Cancer Pain Management Market - Argentina
      • 10.7.8.1. Argentina: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
      • 10.7.8.2. Argentina.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
      • 10.7.8.3. Argentina: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
      • 10.7.8.4. Argentina: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
      • 10.7.8.5. Argentina: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. BioDelivery Sciences
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Daiichi Sankyo
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Eli Lilly & Company
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Endo Pharmaceuticals
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Johnson & Johnson Inc
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Mallinckrodt Pharmaceuticals
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Pfizer Inc
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Prostrakan Group
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Sanofi S.A.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Teva Pharmaceuticals
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development

List of Tables

  • Table 1 Global Cancer Pain Management Market, by Pain Type, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Cancer Pain Management Market, by Drug Type, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Cancer Pain Management Market, by Cancer Type, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Cancer Pain Management Market, by End-Use, by Region, 2019-2032 (USD Billion)
  • Table 5 Global Cancer Pain Management Market, by Application, by Region, 2019-2032 (USD Billion)
  • Table 6 North America: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 7 North America: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 8 North America: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 9 North America: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 10 North America: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 11 U.S.: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 12 U.S.: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 13 U.S.: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 14 U.S.: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 15 U.S.: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 16 Canada: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 17 Canada: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 18 Canada: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 19 Canada: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 20 Canada: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 21 Europe: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 22 Europe: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 23 Europe: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 24 Europe: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 25 Europe: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 26 Germany: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 27 Germany: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 28 Germany: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 29 Germany: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 30 Germany: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 31 France: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 32 France: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 33 France: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 34 France: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 35 France: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 36 UK: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 37 UK: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 38 UK: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 39 UK: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 40 UK: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 41 Italy: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 42 Italy: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 43 Italy: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 44 Italy: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 45 Italy: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 46 Netherlands: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 47 Netherlands: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 48 Netherlands: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 49 Netherlands: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 50 Netherlands: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 51 Spain: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 52 Spain: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 53 Spain: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 54 Spain: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 55 Spain: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 56 Russia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 57 Russia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 58 Russia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 59 Russia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 60 Russia: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 61 Asia Pacific: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 62 Asia Pacific: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 63 Asia Pacific: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 64 Asia Pacific: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 65 Asia Pacific: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 66 China: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 67 China: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 68 China: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 69 China: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 70 China: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 71 Japan: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 72 Japan: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 73 Japan: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 74 Japan: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 75 Japan: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 76 India: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 77 India: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 78 India: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 79 India: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 80 India: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 81 Indonesia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 82 Indonesia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 83 Indonesia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 84 Indonesia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 85 Indonesia: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 86 Malaysia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 87 Malaysia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 88 Malaysia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 89 Malaysia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 90 Malaysia: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 91 South Korea: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 92 South Korea: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 93 South Korea: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 94 South Korea: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 95 South Korea: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 96 Latin America: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 97 Latin America: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 98 Latin America: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 99 Latin America: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 100 Latin America: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 101 Brazil: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 102 Brazil: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 103 Brazil: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 104 Brazil: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 105 Brazil: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 106 Mexico: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 107 Mexico: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 108 Mexico: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 109 Mexico: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 110 Mexico: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 111 Argentina: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 112 Argentina: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 113 Argentina: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 114 Argentina: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 115 Argentina: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 116 Middle East & Africa: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 117 Middle East & Africa: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 118 Middle East & Africa: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 119 Middle East & Africa: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 120 Middle East & Africa: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 121 UAE: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 122 UAE: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 123 UAE: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 124 UAE: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 125 UAE: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 126 Saudi Arabia: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 127 Saudi Arabia: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 128 Saudi Arabia: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 129 Saudi Arabia: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 130 Saudi Arabia: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 131 South Africa: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 132 South Africa: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 133 South Africa: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 134 South Africa: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 135 South Africa: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)
  • Table 136 Israel: Cancer Pain Management Market, by Pain Type, 2019-2032 (USD Billion)
  • Table 137 Israel: Cancer Pain Management Market, by Drug Type, 2019-2032 (USD Billion)
  • Table 138 Israel: Cancer Pain Management Market, by Cancer Type, 2019-2032 (USD Billion)
  • Table 139 Israel: Cancer Pain Management Market, by End-Use, 2019-2032 (USD Billion)
  • Table 140 Israel: Cancer Pain Management Market, by Application, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Cancer Pain Management Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Pain Type
  • Figure 7. Global Cancer Pain Management Market, by Pain Type, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Drug Type
  • Figure 9. Global Cancer Pain Management Market, by Drug Type, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Cancer Type
  • Figure 11. Global Cancer Pain Management Market, by Cancer Type, 2021 & 2030 (USD Billion)
  • Figure 12. Market by End-Use
  • Figure 13. Global Cancer Pain Management Market, by End-Use, 2021 & 2030 (USD Billion)
  • Figure 14. Market by Application
  • Figure 15. Global Cancer Pain Management Market, by Application, 2021 & 2030 (USD Billion)